Pure Global

Everolimus Eluting Cobalt Chromium Coronary Stent System - India CDSCO Medical Device Registration

Everolimus Eluting Cobalt Chromium Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2019/000143_939a64cca209e686bba520344ef7539d_8719cc49e551d65117bdb4485bb9eb31. This device is marketed under the brand name Reivas. The license holder is Relisys Medical Devices Limited, and it is classified as Device Class Class C. The approving authority is CDSCO, Zonal office, Hyderabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Everolimus Eluting Cobalt Chromium Coronary Stent System
UID: MFG/MD/2019/000143_939a64cca209e686bba520344ef7539d_8719cc49e551d65117bdb4485bb9eb31

Brand Name

Reivas

Device Class

Class C

Approving Authority

CDSCO, Zonal office, Hyderabad

Product Information

The Everolimus Eluting Cobalt Chromium Coronary Stent System stent is indicated for improving luminal diameter and reducing restenosis for the treatment of โ€œde novoโ€ lesions in native coronary arteries. It is also indicated for treatment of abrupt or threatened closure in patients with failed interventional therapy. The treated lesions length should be less than the nominal stent length (Reivas) with reference vessel diameters โ‰ฅ 2.25 or โ‰ค 5.00mm

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing